Any stock, in context
KREBSBIO · Healthcare
Krebs Biochemicals and Industries Limited
Observation · 15 Oct 2026
How these are readKrebs Biochemicals and Industries closed at ₹60.82 on 15 Oct 2026, 3.8% above its 200-day average and 7.2% above its 50-day average: above both lines. It sits 15.2% below its highest close of the past year, in the middle fifth of its one-year range. Over three months it rose 13.3%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- Crossed above its 200-day average this week
- Thinly traded: under ₹1 crore a day
- vs 200-day
- +3.8%
- the long line
- vs 50-day
- +7.2%
- the short line
- From 52w high
- −15.2%
- ₹38.33₹76.85
- 3 months
- +13.3%
- sector median −2.7% · 31 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · EQ series · median traded value ₹0.03 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- +0.68%
- 1W
- –
- 1M
- +8.09%
- 3M
- +13.28%
- YTD
- –
- 1Y
- −14.37%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.